, Tracking Stock Market Picks
Enter Symbol:
Net Servicos De Comunicacao S.a. (NETC) [hlAlert]

up 15.43 %

Net Servicos De Comunicacao S.a. (NETC) rated Buy with price target $12 by Oscar Gruss

Posted on: Wednesday,  Apr 29, 2009  11:25 AM ET by Oscar Gruss

Oscar Gruss rated Buy Net Servicos De Comunicacao S.a. (NASDAQ: NETC) on 04/29/2009. Previously Oscar Gruss rated Buy Net Servicos De Comunicacao S.a. (NASDAQ:
NETC) on 04/20/2009., when the stock price was $7.19. Since then, Net Servicos De Comunicacao S.a. has gained 15.44% as of 01/29/2015's recent price of $8.30.
If you would have followed the previous Oscar Gruss's recommendation on NETC, you would have gained 15.43% of your investment in 2110 days.

Net Servicos de Comunicacao SA (Net Servicos) is a multiservice holding company engaged in the pay-television and broadband Internet industries in Brazil. As of December 31, 2008, the Company had 3.2 million connected subscribers in 91 cities in Brazil, including Sao Paulo and Rio de Janeiro. The Company?s principal services include pay-television and pay-per-view programming under the NET brand name, digital cable under the NET Digital brand name, high-definition cable television combined with digital video recorder under the NET Digital HD MAX brand name, broadband Internet service under the NET Virtua brand name and fixed line telephony service under the NET Fone Via Embratel brand name. As of December 31, 2008, the Company?s advanced network of coaxial and fiber-optic cable covered over 47,000 kilometers and passed approximately 10.2 million homes. On December 29, 2008, the Company completed the acquisition of BIGTV, whereby BIGTV became a wholly owned subsidiary of Net Servicos.

Oscar Gruss & Son Inc. is a full service investment and merchant bank. It provides financial advisory services such as mergers and acquisitions, re-capitalization, strategic partnerships and joint venture assignments, fairness opinions, and valuations. Its corporate finance services include public offerings, and placements of equity and debt for public and private companies. It also provides equity research analysis focusing on healthcare, including biotechnology, medical devices, genomics, and other medical technologies; and communications technology, such as telecommunications equipment, and other areas.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/29/2009 11:25 AM Buy
8.18 12.00
as of 12/31/2009
1 Week down  -12.35 %
1 Month down  -18.23 %
3 Months up  1.56 %
1 YTD up  43.03 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/20/2009 10:25 AM Buy
7.19 10.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy